Company intelligence / Profile preview

SafeBlood

Zurich, Zurich, Switzerland
Ownership
Private
Development stage
Other
01

Overview

SafeBlood is an international healthcare organization that facilitates the provision of blood products from donors who have not received mRNA-based vaccines. Founded in 2022 by George Della Pietra, the organization operates a global network to connect patients with unvaccinated donors through a directed donation model. SafeBlood provides a membership-based platform that coordinates with medical clinics and professionals willing to perform transfusions using these specific blood sources. The organization aims to offer an alternative for individuals concerned about the safety of the general blood supply following mass mRNA vaccination campaigns. It currently maintains a presence in over 80 countries, focusing on patient advocacy and donor-recipient matching.

Therapeutic areas
Hematology
Industry
Non-Academic Healthcare

Beyond the preview

Go deeper on SafeBlood.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SafeBlood.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call